Salud financiera de hoja de balance de Dawnrays Pharmaceutical (Holdings)
Salud financiera controles de criterios 6/6
Dawnrays Pharmaceutical (Holdings) tiene un patrimonio de accionistas total de CN¥3.3B y una deuda total de CN¥182.6M, lo que sitúa su ratio deuda-patrimonio en 5.6%. Sus activos y pasivos totales son CN¥4.0B y CN¥773.4M respectivamente. El BAIT de Dawnrays Pharmaceutical (Holdings) es de CN¥229.0M, por lo que su ratio de cobertura de intereses es de -8.1. Tiene efectivo e inversiones a corto plazo que ascienden a CN¥1.7B.
Información clave
5.6%
Ratio deuda-patrimonio
CN¥182.55m
Deuda
| Ratio de cobertura de intereses | -8.1x |
| Efectivo | CN¥1.69b |
| Patrimonio | CN¥3.27b |
| Total pasivo | CN¥773.44m |
| Activos totales | CN¥4.04b |
Actualizaciones recientes sobre salud financiera
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (CN¥2.2B) de 2348 superan a sus pasivos a corto plazo (CN¥655.9M).
Pasivo a largo plazo: Los activos a corto plazo de 2348 (CN¥2.2B) superan a sus pasivos a largo plazo (CN¥117.6M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 2348 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 2348 ha pasado de 10% a 5.6% en los últimos 5 años.
Cobertura de la deuda: La deuda de 2348 está bien cubierta por el flujo de caja operativo (173.9%).
Cobertura de intereses: 2348 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.